{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:16:32Z","timestamp":1789035392428,"version":"build-2803163510"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shandong Province Traditional Chinese Medicine Science & Technology Project","award":["M20252204"],"award-info":[{"award-number":["M20252204"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82403873"],"award-info":[{"award-number":["82403873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Science and Technology Program","award":["RCBS20231211090659098"],"award-info":[{"award-number":["RCBS20231211090659098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13105-026-01230-x","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:30:57Z","timestamp":1789029057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting lncRNA-regulated macrophage polarization: a novel therapeutic strategy for pancreatic ductal adenocarcinoma"],"prefix":"10.1007","volume":"82","author":[{"given":"Hongshi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"1230_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348","journal-title":"CA Cancer J Clin"},{"key":"1230_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41591-024-03362-3","volume":"31","author":"AM Varghese","year":"2025","unstructured":"Varghese AM, Perry MA, Chou JF, Nandakumar S, Muldoon D, Erakky A, Zucker A, Fong C, Mehine M, Nguyen B et al (2025) Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival. Nat Med 31:466\u2013477","journal-title":"Nat Med"},{"key":"1230_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL (2023) Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance. Annu Rev Pathol 18:123\u2013148","journal-title":"Annu Rev Pathol"},{"key":"1230_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A (2023) Pancreatic cancer: Advances and challenges. Cell 186:1729\u20131754","journal-title":"Cell"},{"key":"1230_CR5","doi-asserted-by":"publisher","unstructured":"Pihlak R, Weaver JMJ, Valle JW, McNamara MG (2018) Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy. Cancers (Basel) 10. https:\/\/doi.org\/10.3390\/cancers10010017","DOI":"10.3390\/cancers10010017"},{"key":"1230_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1158\/2159-8290.CD-18-0123","volume":"8","author":"E Riquelme","year":"2018","unstructured":"Riquelme E, Maitra A, McAllister F (2018) Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling. Cancer Discov 8:386\u2013388","journal-title":"Cancer Discov"},{"key":"1230_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, Yang G, Zhou W, Qiu J, Chen G, Luo W, Zhao F, You L, Zheng L, Zhang T, Zhao Y (2021) Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol 14:14","journal-title":"J Hematol Oncol"},{"key":"1230_CR8","doi-asserted-by":"crossref","unstructured":"Huber M, Brehm CU, Gress TM, Buchholz M, Alashkar Alhamwe B, von Strandmann EP, Slater EP, Bartsch JW, Bauer C, Lauth M (2020) The Immune Microenvironment in Pancreatic Cancer. Int J Mol Sci 21","DOI":"10.3390\/ijms21197307"},{"key":"1230_CR9","doi-asserted-by":"publisher","unstructured":"Timmer FEF, Geboers B, Nieuwenhuizen S, Dijkstra M, Schouten EAC, Puijk RS, de Vries JJJ, van den Tol MP, Bruynzeel AME, Streppel MM et al (2021) Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13164138","DOI":"10.3390\/cancers13164138"},{"key":"1230_CR10","doi-asserted-by":"publisher","first-page":"105655","DOI":"10.1016\/j.compbiomed.2022.105655","volume":"148","author":"Y Guo","year":"2022","unstructured":"Guo Y, Li G, Xu M, Peng B (2022) A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma. Comput Biol Med 148:105655","journal-title":"Comput Biol Med"},{"key":"1230_CR11","doi-asserted-by":"publisher","unstructured":"Perez-Medina M, Benito-Lopez JJ, Aguilar-Cazares D, Lopez-Gonzalez JS (2025) A Comprehensive Review of Long Non-Coding RNAs in the Cancer-Immunity Cycle: Mechanisms and Therapeutic Implications. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26104821","DOI":"10.3390\/ijms26104821"},{"key":"1230_CR12","doi-asserted-by":"crossref","unstructured":"Martinez-Castillo M, Lopez-Berestein AME, Amero G, Rodriguez-Aguayo P (2023) C: An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer. Noncoding RNA 9","DOI":"10.3390\/ncrna9060070"},{"key":"1230_CR13","doi-asserted-by":"publisher","first-page":"1191913","DOI":"10.3389\/fonc.2023.1191913","volume":"13","author":"DT Zhan","year":"2023","unstructured":"Zhan DT, Xian HC (2023) Exploring the regulatory role of lncRNA in cancer immunity. Front Oncol 13:1191913","journal-title":"Front Oncol"},{"key":"1230_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41419-024-06876-3","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Gong Y, Ding Y, Sun S, Bai R, Zhuo S, Zhang Z (2024) LINC01133 promotes pancreatic ductal adenocarcinoma epithelial-mesenchymal transition mediated by SPP1 through binding to Arp3. Cell Death Dis 15:492","journal-title":"Cell Death Dis"},{"key":"1230_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/s12967-023-04757-5","volume":"21","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhou X, Ben Q, Liu N, Wang J, Zhai Y, Bao Y, Zhou L (2023) GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability. J Transl Med 21:882","journal-title":"J Transl Med"},{"key":"1230_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1365-2249.1998.00511.x","volume":"111","author":"K Arai","year":"1998","unstructured":"Arai K, Yamamura S, Seki S, Hanyu T, Takahashi HE, Abo T (1998) Increase of CD57\u2009+\u2009T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role. Clin Exp Immunol 111:345\u2013352","journal-title":"Clin Exp Immunol"},{"key":"1230_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10555-021-09995-x","volume":"40","author":"LF Sempere","year":"2021","unstructured":"Sempere LF, Powell K, Rana J, Brock AA, Schmittgen TD (2021) Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. Cancer Metastasis Rev 40:761\u2013776","journal-title":"Cancer Metastasis Rev"},{"key":"1230_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.21037\/atm-20-695","volume":"8","author":"V Nadella","year":"2020","unstructured":"Nadella V, Garg M, Kapoor S, Barwal TS, Jain A, Prakash H (2020) Emerging neo adjuvants for harnessing therapeutic potential of M1 tumor associated macrophages (TAM) against solid tumors: Enusage of plasticity. Ann Transl Med 8:1029","journal-title":"Ann Transl Med"},{"key":"1230_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","volume":"24","author":"S Ma","year":"2023","unstructured":"Ma S, Sun B, Duan S, Han J, Barr T, Zhang J, Bissonnette MB, Kortylewski M, He C, Chen J et al (2023) YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8(+) T cells. Nat Immunol 24:255\u2013266","journal-title":"Nat Immunol"},{"key":"1230_CR20","doi-asserted-by":"crossref","unstructured":"Li C, Xu X, Wei S, Jiang P, Xue L, Wang J (2021) Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer 9","DOI":"10.1136\/jitc-2020-001341"},{"key":"1230_CR21","doi-asserted-by":"crossref","unstructured":"Boutilier AJ, Elsawa SF (2021) Macrophage Polarization States in the Tumor Microenvironment. Int J Mol Sci 22","DOI":"10.3390\/ijms22136995"},{"key":"1230_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L (2020) The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol 17:527\u2013540","journal-title":"Nat Rev Clin Oncol"},{"key":"1230_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-023-02890-z","volume":"42","author":"J Lin","year":"2023","unstructured":"Lin J, Liu Y, Liu P, Qi W, Liu J, He X, Liu Q, Liu Z, Yin J, Lin J et al (2023) SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res 42:339","journal-title":"J Exp Clin Cancer Res"},{"key":"1230_CR24","doi-asserted-by":"publisher","first-page":"215751","DOI":"10.1016\/j.canlet.2022.215751","volume":"548","author":"Z He","year":"2022","unstructured":"He Z, Wang J, Zhu C, Xu J, Chen P, Jiang X, Chen Y, Jiang J, Sun C (2022) Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Lett 548:215751","journal-title":"Cancer Lett"},{"key":"1230_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41568-021-00353-1","volume":"21","author":"SJ Liu","year":"2021","unstructured":"Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA (2021) Long noncoding RNAs in cancer metastasis. Nat Rev Cancer 21:446\u2013460","journal-title":"Nat Rev Cancer"},{"key":"1230_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12935-022-02741-5","volume":"22","author":"J Yao","year":"2022","unstructured":"Yao J, Gao R, Luo M, Li D, Guo L, Yu Z, Xiong F, Wei C, Wu B, Xu Z et al (2022) Exosomal LINC00460\/miR-503-5p\/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint. Cancer Cell Int 22:390","journal-title":"Cancer Cell Int"},{"key":"1230_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-biochem-062917-012708","volume":"89","author":"JL Rinn","year":"2020","unstructured":"Rinn JL, Chang HY (2020) Long Noncoding RNAs: Molecular Modalities to Organismal Functions. Annu Rev Biochem 89:283\u2013308","journal-title":"Annu Rev Biochem"},{"key":"1230_CR28","unstructured":"Wang C, Li Y, Tian BA-O LINC00852 Enhances Glycolysis and Tumor Immunity in Pancreatic Cancer via the miR\u2013494\u20133p\/GPX8 Axis."},{"key":"1230_CR29","unstructured":"Zhou WY, Zhang MM, Liu C, Kang Y, Wang JO, Yang XA-O Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p"},{"key":"1230_CR30","doi-asserted-by":"crossref","unstructured":"Zhu D, Shen R, Li M (2026) METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability. Eur J Med Res 31","DOI":"10.1186\/s40001-026-03963-3"},{"key":"1230_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7150\/jca.21749","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Wang S, Jia S, Ding G, Jiang G, Cao L (2018) Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis. J Cancer 9:21\u201331","journal-title":"J Cancer"},{"key":"1230_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","volume":"26","author":"M Shakiba","year":"2025","unstructured":"Shakiba M, Tuveson DA (2025) Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer. Nat Immunol 26:678\u2013691","journal-title":"Nat Immunol"},{"key":"1230_CR33","doi-asserted-by":"publisher","first-page":"104965","DOI":"10.1016\/j.critrevonc.2025.104965","volume":"216","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang D, Liu X, Xu M, He J, Ma J, Yang Z (2025) Dynamic crosstalk between tumor-associated macrophages and cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Crit Rev Oncol Hematol 216:104965","journal-title":"Crit Rev Oncol Hematol"},{"key":"1230_CR34","doi-asserted-by":"publisher","first-page":"607209","DOI":"10.3389\/fcell.2020.607209","volume":"8","author":"S Yang","year":"2020","unstructured":"Yang S, Liu Q, Liao Q (2020) Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. Front Cell Dev Biol 8:607209","journal-title":"Front Cell Dev Biol"},{"key":"1230_CR35","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1158\/0008-5472.CAN-20-3929","volume":"81","author":"SB Kemp","year":"2021","unstructured":"Kemp SB, Carpenter ES, Steele NG, Donahue KL, Nwosu ZC, Pacheco A, Velez-Delgado A, Menjivar RE, Lima F, The S et al (2021) Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-\u03baB-Mediated Production of CXCL1. Cancer Res 81:4305\u20134318","journal-title":"Cancer Res"},{"key":"1230_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/2326-6066.CIR-23-0037","volume":"12","author":"W Yan","year":"2024","unstructured":"Yan W, Menjivar RE, Bonilla ME, Steele NG, Kemp SB, Du W, Donahue KL, Brown KL, Carpenter ES, Avritt FR et al (2024) Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer. Cancer Immunol Res 12:91\u2013106","journal-title":"Cancer Immunol Res"},{"key":"1230_CR37","unstructured":"LaRue MM, Parker SA-O, Puccini J, Cammer M, Kimmelman AC, Bar-Sagi D Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer"},{"key":"1230_CR38","unstructured":"Werba GA-O, Weissinger D, Kawaler EA, Zhao E, Kalfakakou DA-O, Dhara S, Wang L, Lim HB, Oh G, Jing X et al Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment"},{"key":"1230_CR39","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.1002\/ctm2.654","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang X, Zhu Y, Cao Y, Wang L, Li F, Zhang Y, Li Y, Zhang Z, Luo J et al (2022) The CTCF\/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression. Clin Transl Med 12:e654","journal-title":"Clin Transl Med"},{"key":"1230_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41419-025-07720-y","volume":"16","author":"T Ma","year":"2025","unstructured":"Ma T, Guo WW, Zhang M, He W, Dongzhi C, Gongye X, Xia P, Chai Y, Chen Z, Zhu Y et al (2025) Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma. Cell Death Dis 16:382","journal-title":"Cell Death Dis"},{"key":"1230_CR41","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ymthe.2020.11.024","volume":"29","author":"Y Yang","year":"2021","unstructured":"Yang Y, Guo Z, Chen W, Wang X, Cao M, Han X, Zhang K, Teng B, Cao J, Wu W et al (2021) M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2. Mol Ther 29:1226\u20131238","journal-title":"Mol Ther"},{"key":"1230_CR42","doi-asserted-by":"publisher","first-page":"217389","DOI":"10.1016\/j.canlet.2024.217389","volume":"611","author":"P Liu","year":"2024","unstructured":"Liu P, Gao X, Yu Z, Liu Y, Liu Y, Lin J, Cao Y, Zhai S, Li J, Huang Y et al (2024) H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression. Cancer Lett 611:217389","journal-title":"Cancer Lett"},{"key":"1230_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-025-03321-x","volume":"44","author":"S Dong","year":"2025","unstructured":"Dong S, Li X, Chen Z, Shi H, Wang Z, Zhou W (2025) MMP28 recruits M2-type tumor-associated macrophages through MAPK\/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer. J Exp Clin Cancer Res 44:60","journal-title":"J Exp Clin Cancer Res"},{"key":"1230_CR44","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tcb.2023.03.008","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu J, Cao X (2023) Glucose metabolism of TAMs in tumor chemoresistance and metastasis. Trends Cell Biol 33:967\u2013978","journal-title":"Trends Cell Biol"},{"key":"1230_CR45","doi-asserted-by":"publisher","first-page":"1573039","DOI":"10.3389\/fimmu.2025.1573039","volume":"16","author":"X Jin","year":"2025","unstructured":"Jin X, Zhang N, Yan T, Wei J, Hao L, Sun C, Zhao H, Jiang S (2025) Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential. Front Immunol 16:1573039","journal-title":"Front Immunol"},{"key":"1230_CR46","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/cancers6031670","volume":"6","author":"T Chanmee","year":"2014","unstructured":"Chanmee T, Ontong P, Konno K, Itano N (2014) Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel) 6:1670\u20131690","journal-title":"Cancers (Basel)"},{"key":"1230_CR47","doi-asserted-by":"crossref","unstructured":"Boyer S, Lee HJ, Steele N, Zhang L, Sajjakulnukit P, Andren A, Ward MH, Singh R, Basrur V, Zhang Y et al (2022) Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF-PI3K pathway. Elife 11","DOI":"10.7554\/eLife.73796"},{"key":"1230_CR48","doi-asserted-by":"publisher","first-page":"216784","DOI":"10.1016\/j.canlet.2024.216784","volume":"588","author":"Z Zhong","year":"2024","unstructured":"Zhong Z, Yang K, Li Y, Zhou S, Yao H, Zhao Y, Huang Y, Zou J, Li Y, Jiajia L et al (2024) Tumor-associated macrophages drive glycolysis through the IL-8\/STAT3\/GLUT3 signaling pathway in pancreatic cancer progression. Cancer Lett 588:216784","journal-title":"Cancer Lett"},{"key":"1230_CR49","doi-asserted-by":"publisher","first-page":"3274467","DOI":"10.1155\/2023\/3274467","volume":"2023","author":"K Wang","year":"2023","unstructured":"Wang K, He M, Fan X, Zhou J, Yang J, Wang L, Zhao Z, Dai C, Zhang Z (2023) SEMA5A-PLXNB3 Axis Promotes PDAC Liver Metastasis Outgrowth through Enhancing the Warburg Effect. J Immunol Res 2023:3274467","journal-title":"J Immunol Res"},{"key":"1230_CR50","doi-asserted-by":"publisher","first-page":"1560393","DOI":"10.3389\/fimmu.2025.1560393","volume":"16","author":"H Jin","year":"2025","unstructured":"Jin H, Meng X, Feng J (2025) Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy. Front Immunol 16:1560393","journal-title":"Front Immunol"},{"key":"1230_CR51","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1158\/0008-5472.CAN-20-3929","volume":"81","author":"SB Kemp","year":"2021","unstructured":"Kemp SB, Carpenter ES, Steele NG, Donahue KL, Nwosu ZC, Pacheco A, Velez-Delgado A, Menjivar RE, Lima F, The S et al (2021) Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-kappaB-Mediated Production of CXCL1. Cancer Res 81:4305\u20134318","journal-title":"Cancer Res"},{"key":"1230_CR52","first-page":"228","volume":"26","author":"W Ge","year":"2023","unstructured":"Ge W, Wu W (2023) [Influencing Factors and Significance of Tumor-associated Macrophage Polarization in Tumor Microenvironment]. Zhongguo Fei Ai Za Zhi 26:228\u2013237","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"1230_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2020.04.018","volume":"484","author":"A Yamasaki","year":"2020","unstructured":"Yamasaki A, Yanai K, Onishi H (2020) Hypoxia and pancreatic ductal adenocarcinoma. Cancer Lett 484:9\u201315","journal-title":"Cancer Lett"},{"key":"1230_CR54","doi-asserted-by":"publisher","first-page":"110665","DOI":"10.1016\/j.ygeno.2023.110665","volume":"115","author":"J Sun","year":"2023","unstructured":"Sun J, Zhu S (2023) Identifying the role of hypoxia-related lncRNAs in pancreatic cancer. Genomics 115:110665","journal-title":"Genomics"},{"key":"1230_CR55","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.7150\/thno.34559","volume":"9","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Xu FY, Zheng H, Cheng P, Chen QY, Ye Z, Zhong JX, Deng SJ, Liu ML, Huang K et al (2019) LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1\u03b1. Theranostics 9:5298\u20135314","journal-title":"Theranostics"},{"key":"1230_CR56","doi-asserted-by":"publisher","first-page":"156037","DOI":"10.1016\/j.phymed.2024.156037","volume":"135","author":"Y Gu","year":"2024","unstructured":"Gu Y, Dong Z, Gu Y, Gao Y, Li D, Zhang Y, Zhang X (2024) Paeoniae radix alba improved intestinal mucosal microcirculation disturbance by regulating lncRNA MALAT1\/HIF-1\u03b1 pathway in the treatment of ulcerative colitis. Phytomedicine 135:156037","journal-title":"Phytomedicine"},{"key":"1230_CR57","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.7150\/ijbs.99680","volume":"20","author":"X Zhao","year":"2024","unstructured":"Zhao X, Ren T, Li S, Wang X, Hou R, Guan Z, Liu D, Zheng J, Shi M (2024) A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells. Int J Biol Sci 20:5109\u20135126","journal-title":"Int J Biol Sci"},{"key":"1230_CR58","doi-asserted-by":"crossref","unstructured":"Dalmasso B, Ghiorzo P (2023) Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer. Cancers (Basel) 15","DOI":"10.3390\/cancers15133486"},{"key":"1230_CR59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12935-021-02142-0","volume":"21","author":"X Yin","year":"2021","unstructured":"Yin X, Yang J, Chen J, Ni R, Zhou Y, Song H, Jin L, Tang T, Pan Y (2021) LncRNA CTD-3252C9.4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription. Cancer Cell Int 21:433","journal-title":"Cancer Cell Int"},{"key":"1230_CR60","doi-asserted-by":"publisher","first-page":"1625114","DOI":"10.3389\/fimmu.2025.1625114","volume":"16","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Zhang H, Wang Z, Huang L, Kabacaoglu D, Zhang B, Song L, Ai J (2025) The role of inflammatory factors in the tumor microenvironment of pancreatic cancer. Front Immunol 16:1625114","journal-title":"Front Immunol"},{"key":"1230_CR61","doi-asserted-by":"publisher","first-page":"1237711","DOI":"10.3389\/fimmu.2023.1237711","volume":"14","author":"P Storz","year":"2023","unstructured":"Storz P (2023) Roles of differently polarized macrophages in the initiation and progressionof pancreatic cancer. Front Immunol 14:1237711","journal-title":"Front Immunol"},{"key":"1230_CR62","unstructured":"Li MX, Wang HY, Yuan CH, Ma ZL, Jiang B, Li L, Zhang L, Xiu DR KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages"},{"key":"1230_CR63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrneph.2016.51","volume":"12","author":"JM Lorenzen","year":"2016","unstructured":"Lorenzen JM, Thum T (2016) Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol 12:360\u2013373","journal-title":"Nat Rev Nephrol"},{"key":"1230_CR64","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904\u2013914","journal-title":"Mol Cell"},{"key":"1230_CR65","doi-asserted-by":"crossref","unstructured":"Chen B, Li J, Chi D, Sahnoune I, Calin S, Girnita L, Calin GA (2019) Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer. Cells 8","DOI":"10.3390\/cells8121638"},{"key":"1230_CR66","doi-asserted-by":"crossref","unstructured":"Wang Y, Liu H, Zhang M, Xu J, Zheng L, Liu P, Chen J, Liu H, Chen C Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives. MedComm (2020) 2024, 5:e670","DOI":"10.1002\/mco2.670"},{"key":"1230_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Ma T, Yu B (2023) Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther 8:69","journal-title":"Signal Transduct Target Ther"},{"key":"1230_CR68","doi-asserted-by":"publisher","first-page":"108547","DOI":"10.1016\/j.pharmthera.2023.108547","volume":"251","author":"W Rungratanawanich","year":"2023","unstructured":"Rungratanawanich W, Ballway JW, Wang X, Won KJ, Hardwick JP, Song BJ (2023) Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease: Challenges and research opportunities. Pharmacol Ther 251:108547","journal-title":"Pharmacol Ther"},{"key":"1230_CR69","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41418-024-01423-1","volume":"32","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu P, Duan S, Lin J, Qi W, Yu Z, Gao X, Sun X, Liu J, Lin J et al (2025) CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Cell Death Differ 32:745\u2013762","journal-title":"Cell Death Differ"},{"key":"1230_CR70","doi-asserted-by":"publisher","first-page":"112112","DOI":"10.1016\/j.biopha.2021.112112","volume":"142","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Abak A, Tavakkoli Avval S, Shoorei H, Taheri M, Samadian M (2021) The impact of non-coding RNAs on macrophage polarization. Biomed Pharmacother 142:112112","journal-title":"Biomed Pharmacother"},{"key":"1230_CR71","doi-asserted-by":"publisher","first-page":"118895","DOI":"10.1016\/j.lfs.2020.118895","volume":"266","author":"R Dong","year":"2021","unstructured":"Dong R, Zhang B, Tan B, Lin N (2021) Long non-coding RNAs as the regulators and targets of macrophage M2 polarization. Life Sci 266:118895","journal-title":"Life Sci"},{"key":"1230_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12935-023-03186-0","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Peng M, Tan S, Oyang L, Lin J, Xia L, Wang J, Wu N, Jiang X, Peng Q et al (2024) The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. Cancer Cell Int 24:37","journal-title":"Cancer Cell Int"},{"key":"1230_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-022-01272-w","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shi M, He X, Cao Y, Liu P, Li F, Zou S, Wen C, Zhan Q, Xu Z et al (2022) LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J Hematol Oncol 15:52","journal-title":"J Hematol Oncol"},{"key":"1230_CR74","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/08923973.2022.2145968","volume":"45","author":"T Zhang","year":"2023","unstructured":"Zhang T, Yu H, Bai Y, Song J, Chen J, Li Y, Cui Y (2023) Extracellular vesicle-derived LINC00511 promotes glycolysis and mitochondrial oxidative phosphorylation of pancreatic cancer through macrophage polarization by microRNA-193a-3p-dependent regulation of plasminogen activator urokinase. Immunopharmacol Immunotoxicol 45:355\u2013369","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1230_CR75","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1111\/jcmm.15125","volume":"24","author":"Z Yin","year":"2020","unstructured":"Yin Z, Zhou Y, Ma T, Chen S, Shi N, Zou Y, Hou B, Zhang C (2020) Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development. J Cell Mol Med 24:5028\u20135038","journal-title":"J Cell Mol Med"},{"key":"1230_CR76","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750\u2013761","journal-title":"Nat Rev Immunol"},{"key":"1230_CR77","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/CS20201259","volume":"135","author":"MX Li","year":"2021","unstructured":"Li MX, Wang HY, Yuan CH, Ma ZL, Jiang B, Li L, Zhang L, Xiu DR (2021) KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages. Clin Sci (Lond) 135:629\u2013649","journal-title":"Clin Sci (Lond)"},{"key":"1230_CR78","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1158\/0008-5472.CAN-24-4784","volume":"85","author":"YD Wu","year":"2025","unstructured":"Wu YD, Huang XX, Zhang HX, Pan Y, Xie CK, Li G, Lin CF, Lin XQ, Li ZY, Chen YH et al (2025) TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. Cancer Res 85:3292\u20133312","journal-title":"Cancer Res"},{"key":"1230_CR79","unstructured":"Feng L, Wang Y, Wang X, Li B, Liu Y, Zhang W, Ji J, Shao L, Guo X Exosomal lncRNA MIR210HG derived from hypoxic TAMs promotes the metastasis of triple negative breast cancer"},{"key":"1230_CR80","unstructured":"Han XA-O, Huang SA-O, Xue PA-O, Fu JA-O, Liu L, Zhang C, Yang L, Xia L, Sun L, Huang SK Zhou YA-O: LncRNA PTPRE-AS1 modulates M2 macrophage activation and inflammatory diseases by epigenetic promotion of PTPRE"},{"key":"1230_CR81","unstructured":"Yin C, Li J, Li S, Yang X, Lu Y, Wang C, Liu B LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1\/SOCS1 and STAT1\/CIITA pathways to promote the progression of non-small cell lung cancer"},{"key":"1230_CR82","unstructured":"Xie C, Guo Y, Lou S LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization"},{"key":"1230_CR83","doi-asserted-by":"crossref","unstructured":"Peshin S, Takrori E, Kodali NA, Bashir F, Singal S (2025) Advances in the Management of Pancreatic Cancer: Current Strategies and Emerging Therapies. Int J Mol Sci 26","DOI":"10.3390\/ijms26157055"},{"key":"1230_CR84","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11864-025-01352-2","volume":"26","author":"C Peng","year":"2025","unstructured":"Peng C, Oberstein PE (2025) Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions. Curr Treat Options Oncol 26:841\u2013865","journal-title":"Curr Treat Options Oncol"},{"key":"1230_CR85","first-page":"451","volume":"21","author":"X Kong","year":"2024","unstructured":"Kong X, Zhang J, Chen S, Wang X, Xi Q, Shen H, Zhang R (2024) Immune checkpoint inhibitors: breakthroughs in cancer treatment. Cancer Biol Med 21:451\u2013472","journal-title":"Cancer Biol Med"},{"key":"1230_CR86","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1200\/JCO.21.02616","volume":"40","author":"NA Ullman","year":"2022","unstructured":"Ullman NA, Burchard PR, Dunne RF, Linehan DC (2022) Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot. J Clin Oncol 40:2789\u20132805","journal-title":"J Clin Oncol"},{"key":"1230_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","volume":"82","author":"HO Iwakawa","year":"2022","unstructured":"Iwakawa HO, Tomari Y (2022) Life of RISC: Formation, action, and degradation of RNA-induced silencing complex. Mol Cell 82:30\u201343","journal-title":"Mol Cell"},{"key":"1230_CR88","doi-asserted-by":"publisher","first-page":"120463","DOI":"10.1016\/j.lfs.2022.120463","volume":"298","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Saebfar H, Mahabady MK, Orouei S, Hushmandi K, Entezari M, Hashemi M, Aref AR, Hamblin MR, Ang HL et al (2022) Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sci 298:120463","journal-title":"Life Sci"},{"key":"1230_CR89","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.7150\/ijbs.70289","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zheng X, Yu Y, Zheng L, Lan J, Wu Y, Liu H, Zhao A, Huang H, Chen W (2022) Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway. Int J Biol Sci 18:3209\u20133222","journal-title":"Int J Biol Sci"},{"key":"1230_CR90","doi-asserted-by":"publisher","first-page":"1506561","DOI":"10.3389\/fimmu.2024.1506561","volume":"15","author":"H Shi","year":"2024","unstructured":"Shi H, Wang P, Wang J, Chen L, Qin Y, Lv J (2024) Global lncRNA expression signature in pre-metastatic lung and their regulatory effects in pulmonary metastasis. Front Immunol 15:1506561","journal-title":"Front Immunol"},{"key":"1230_CR91","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1002\/ctm2.407","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Xia L, Liu F, Tian Y, Chen R, Su Z (2021) lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C\/EBP\u03b2-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clin Transl Med 11:e407","journal-title":"Clin Transl Med"},{"key":"1230_CR92","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.omtn.2020.10.009","volume":"22","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Teng Y, Xiao W, Xu B, Zhao Y, Li W, Wu L (2020) Identifying Cleaved and Noncleaved Targets of Small Interfering RNAs and MicroRNAs in Mammalian Cells by SpyCLIP. Mol Ther Nucleic Acids 22:900\u2013909","journal-title":"Mol Ther Nucleic Acids"},{"key":"1230_CR93","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrm.2016.174","volume":"18","author":"SA Gorski","year":"2017","unstructured":"Gorski SA, Vogel J, Doudna JA (2017) RNA-based recognition and targeting: sowing the seeds of specificity. Nat Rev Mol Cell Biol 18:215\u2013228","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1230_CR94","unstructured":"Friedrich MA-O, Aigner AA-O Therapeutic siRNA: State-of-the-Art and Future Perspectives"},{"key":"1230_CR95","unstructured":"Xin Y, Huang M, Guo WW, Huang Q, Zhang LZ, Jiang GA-O Nano-based delivery of RNAi in cancer therapy"},{"key":"1230_CR96","unstructured":"McCarroll J, Teo J, Boyer C, Goldstein D, Kavallaris M, Phillips PA Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer"},{"key":"1230_CR97","unstructured":"Lennox KA, Behlke MA Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides"},{"key":"1230_CR98","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mib.2014.07.001","volume":"19","author":"E Charpentier","year":"2014","unstructured":"Charpentier E, Marraffini LA (2014) Harnessing CRISPR-Cas9 immunity for genetic engineering. Curr Opin Microbiol 19:114\u2013119","journal-title":"Curr Opin Microbiol"},{"key":"1230_CR99","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.celrep.2015.02.002","volume":"10","author":"BJ Aubrey","year":"2015","unstructured":"Aubrey BJ, Kelly GL, Kueh AJ, Brennan MS, O\u2019Connor L, Milla L, Wilcox S, Tai L, Strasser A, Herold MJ (2015) An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep 10:1422\u20131432","journal-title":"Cell Rep"},{"key":"1230_CR100","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cell.2015.01.001","volume":"160","author":"CE Antal","year":"2015","unstructured":"Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB et al (2015) Cancer-associated protein kinase C mutations reveal kinase\u2019s role as tumor suppressor. Cell 160:489\u2013502","journal-title":"Cell"},{"key":"1230_CR101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","volume":"26","author":"K Hoppe-Seyler","year":"2018","unstructured":"Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F (2018) The HPV E6\/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends Microbiol 26:158\u2013168","journal-title":"Trends Microbiol"},{"key":"1230_CR102","doi-asserted-by":"publisher","first-page":"19675","DOI":"10.1038\/srep19675","volume":"6","author":"X Liu","year":"2016","unstructured":"Liu X, Homma A, Sayadi J, Yang S, Ohashi J, Takumi T (2016) Sequence features associated with the cleavage efficiency of CRISPR\/Cas9 system. Sci Rep 6:19675","journal-title":"Sci Rep"},{"key":"1230_CR103","doi-asserted-by":"crossref","unstructured":"Kopp F, Elguindy MM, Yalvac ME, Zhang H, Chen B, Gillett FA, Lee S, Sivakumar S, Yu H, Xie Y et al (2019) PUMILIO hyperactivity drives premature aging of Norad-deficient mice. Elife 8","DOI":"10.7554\/eLife.42650"},{"key":"1230_CR104","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore PI, D\u2019Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA (2015) Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods 12:1143\u20131149","journal-title":"Nat Methods"},{"key":"1230_CR105","doi-asserted-by":"publisher","first-page":"e1410","DOI":"10.1002\/ctm2.1410","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Zhou WY, Luo XJ, Chen YX, Wong CW, Liu ZX, Bo Zheng J, Yu Mo H, Chen JQ, Li JJ et al (2023) Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein-1-H3K4me3-mediated immune escape in oesophageal squamous cell carcinoma. Clin Transl Med 13:e1410","journal-title":"Clin Transl Med"},{"key":"1230_CR106","doi-asserted-by":"publisher","first-page":"6979117","DOI":"10.1155\/2022\/6979117","volume":"2022","author":"D Hu","year":"2022","unstructured":"Hu D, Wang Y, You Z, Lu Y, Liang C (2022) lnc-MRGPRF-6:1 Promotes M1 Polarization of Macrophage and Inflammatory Response through the TLR4-MyD88-MAPK Pathway. Mediators Inflamm 2022:6979117","journal-title":"Mediators Inflamm"},{"key":"1230_CR107","unstructured":"Goyal A, Myacheva K, Gro\u00df M, Klingenberg M, Duran Arqu\u00e9 B, Diederichs S Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes"},{"key":"1230_CR108","doi-asserted-by":"publisher","first-page":"122003","DOI":"10.1016\/j.lfs.2023.122003","volume":"330","author":"P Agrawal","year":"2023","unstructured":"Agrawal P, Harish V, Mohd S, Singh SK, Tewari D, Tatiparthi R, Harshita, Vishwas S, Sutrapu S, Dua K, Gulati M (2023) Role of CRISPR\/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies. Life Sci 330:122003","journal-title":"Life Sci"},{"key":"1230_CR109","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12935-019-0726-0","volume":"19","author":"D Ghosh","year":"2019","unstructured":"Ghosh D, Venkataramani P, Nandi S, Bhattacharjee S (2019) CRISPR-Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics. Cancer Cell Int 19:12","journal-title":"Cancer Cell Int"},{"key":"1230_CR110","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/pcmedi\/pbab014","volume":"4","author":"W Liu","year":"2021","unstructured":"Liu W, Li L, Jiang J, Wu M, Lin P (2021) Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics. Precis Clin Med 4:179\u2013191","journal-title":"Precis Clin Med"},{"key":"1230_CR111","unstructured":"Ewaisha R, Anderson KS Immunogenicity of CRISPR therapeutics-Critical considerations for clinical translation"},{"key":"1230_CR112","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/nat.2016.0656","volume":"27","author":"ST Crooke","year":"2017","unstructured":"Crooke ST (2017) Molecular Mechanisms of Antisense Oligonucleotides. Nucleic Acid Ther 27:70\u201377","journal-title":"Nucleic Acid Ther"},{"key":"1230_CR113","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Z, Chen X, Zhang S (2021) Long non-coding RNAs: From disease code to drug role. Acta Pharm Sin B 11:340\u2013354","journal-title":"Acta Pharm Sin B"},{"key":"1230_CR114","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/2326-6066.CIR-23-0045","volume":"11","author":"O Adewunmi","year":"2023","unstructured":"Adewunmi O, Shen Y, Zhang XH, Rosen JM (2023) Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer. Cancer Immunol Res 11:1462\u20131479","journal-title":"Cancer Immunol Res"},{"key":"1230_CR115","unstructured":"Andersson PA-O Preclinical Safety Assessment of Therapeutic Oligonucleotides"},{"key":"1230_CR116","doi-asserted-by":"publisher","first-page":"576399","DOI":"10.3389\/fonc.2020.576399","volume":"10","author":"B Jiang","year":"2020","unstructured":"Jiang B, Zhou L, Lu J, Wang Y, Liu C, You L, Guo J (2020) Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides? Front Oncol 10:576399","journal-title":"Front Oncol"},{"key":"1230_CR117","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","volume":"9","author":"Y Shi","year":"2024","unstructured":"Shi Y, Shi M, Wang Y, You J (2024) Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications. Signal Transduct Target Ther 9:322","journal-title":"Signal Transduct Target Ther"},{"key":"1230_CR118","unstructured":"Gutschner T, H\u00e4mmerle M, Fau - Eissmann M, Eissmann M, Fau - Hsu J, Hsu J, Fau - Kim Y, Kim Y, Fau - Hung G, Hung G, Fau - Revenko A, Revenko A, Fau - Arun G, Arun G, Fau - Stentrup M, Stentrup M, Fau - Gross M, Gross M Fau - Z\u00f6rnig M, : The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells"},{"key":"1230_CR119","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature13905","volume":"518","author":"CJ Cheng","year":"2015","unstructured":"Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM et al (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518:107\u2013110","journal-title":"Nature"},{"key":"1230_CR120","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2026.01.003","volume":"119","author":"M Llena-Meler","year":"2026","unstructured":"Llena-Meler M, Canfran-Duque A, Madrigal-Matute J, Rotllan N (2026) Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. Semin Cancer Biol 119:83\u2013105","journal-title":"Semin Cancer Biol"},{"key":"1230_CR121","unstructured":"Liu Y, Liu P, Duan SA-O, Lin J, Qi W, Yu Z, Gao X, Sun X, Liu J, Lin J et al CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization"},{"key":"1230_CR122","doi-asserted-by":"crossref","unstructured":"Yao Y, Hu Y, Meng X, Feng F, Xu F, Wang G, Yu H, Li J (2024) Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma. Pharm Sci Adv 2","DOI":"10.1016\/j.pscia.2024.100046"},{"key":"1230_CR123","doi-asserted-by":"publisher","first-page":"144357","DOI":"10.1016\/j.ijbiomac.2025.144357","volume":"316","author":"M Wu","year":"2025","unstructured":"Wu M, Sheng J, Xie Q, Qi Y, Zhao Y, Zhang S (2025) Recent advances in stimuli-responsive hyaluronic acid-based nanodelivery systems for cancer treatment: A review. Int J Biol Macromol 316:144357","journal-title":"Int J Biol Macromol"},{"key":"1230_CR124","doi-asserted-by":"crossref","unstructured":"Lokole PB, Ngombe NK, Motomba DI, Safari JB, Mpuza MK, Krause RWM, Mutwale PK, Nkanga CI (2024) Preparation and characterization of micellar nanoparticles using crude saponins from five Congolese plant species. Pharm Sci Adv 2","DOI":"10.1016\/j.pscia.2024.100055"},{"key":"1230_CR125","unstructured":"Yao Y, Hu Y, Meng X, Feng F, Xu F, Wang G, Yu H, Li J"},{"key":"1230_CR126","doi-asserted-by":"publisher","first-page":"45871","DOI":"10.1021\/acsami.4c04893","volume":"16","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Moitra P, Bera S, Bhattacharya S (2024) Antisense Oligonucleotide Embedded Context Responsive Nanoparticles Derived from Synthetic Ionizable Lipids for lncRNA Targeted Therapy of Breast Cancer. ACS Appl Mater Interfaces 16:45871\u201345887","journal-title":"ACS Appl Mater Interfaces"},{"key":"1230_CR127","doi-asserted-by":"publisher","first-page":"124545","DOI":"10.1016\/j.ijpharm.2024.124545","volume":"663","author":"NK Dastgerdi","year":"2024","unstructured":"Dastgerdi NK, Dastgerdi NK, Bayraktutan H, Costabile G, Atyabi F, Dinarvand R, Longobardi G, Alexander C, Conte C (2024) Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems. Int J Pharm 663:124545","journal-title":"Int J Pharm"},{"key":"1230_CR128","doi-asserted-by":"crossref","unstructured":"Connerty P, Moles E, de Bock CE, Jayatilleke N, Smith JL, Meshinchi S, Mayoh C, Kavallaris M, Lock RB (2021) Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia. Pharmaceutics 13","DOI":"10.3390\/pharmaceutics13101681"},{"key":"1230_CR129","doi-asserted-by":"publisher","first-page":"129233","DOI":"10.1016\/j.ijbiomac.2024.129233","volume":"259","author":"M Saeinasab","year":"2024","unstructured":"Saeinasab M, Iranpour S, Hosseini-Giv N, Saljooghi AS, Matin MM (2024) Tumor-targeted delivery of SNHG15 siRNA using a ZIF-8 nanoplatform: Towards a more effective prostate cancer therapy. Int J Biol Macromol 259:129233","journal-title":"Int J Biol Macromol"},{"key":"1230_CR130","unstructured":"Gomes-da-Silva LC, Fonseca Na Fau -, Moura V, Moura V, de Fau - MC, Pedroso de Lima Mc Fau - Sim\u00f5es S, Sim\u00f5es S Fau - Moreira JN, Moreira JN Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges"},{"key":"1230_CR131","unstructured":"Gonz\u00e1lez ZA-O, Ferrandez-Montero AA-O, Dom\u00ednguez-Robles J Recent Advances in Polymers as Matrices for Drug Delivery Applications. LID\u2009\u2013\u200910.3390\/ph16121674IF: 5.7 Q1 B3 [doi] LID\u2009\u2013\u20091674."},{"key":"1230_CR132","unstructured":"Shao W, Paul A, Fau - Abbasi S, Abbasi S, Fau - Chahal PS, Chahal Ps Fau - Mena JA, Mena Ja Fau - Montes J, Montes J, Fau - Kamen A, Kamen A, Fau - Prakash S, Prakash S A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis"},{"key":"1230_CR133","unstructured":"Fang J, Nakamura H, Fau - Maeda H, Maeda H The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect"},{"key":"1230_CR134","unstructured":"Xie Y, Hang Y, Wang Y, Sleightholm R, Prajapati DR, Bader J, Yu A, Tang W, Jaramillo L, Li J et al Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA\/siRNA Nanotherapy"},{"key":"1230_CR135","unstructured":"Qiao MA-O, Zeng CA-O, Liu C, Lei Z, Liu B, Xie H The advancement of siRNA-based nanomedicine for tumor therapy"},{"key":"1230_CR136","doi-asserted-by":"publisher","first-page":"153303382211417","DOI":"10.1177\/15330338221141793","volume":"21","author":"M Cellina","year":"2022","unstructured":"Cellina M, C\u00e8 M, Khenkina N, Sinichich P, Cervelli M, Poggi V, Boemi S, Ierardi AM, Carrafiello G (2022) Artificial Intellgence in the Era of Precision Oncological Imaging. Technol Cancer Res Treat 21:15330338221141793","journal-title":"Technol Cancer Res Treat"},{"key":"1230_CR137","doi-asserted-by":"crossref","unstructured":"Gharaibeh NY, De Fazio R, Al-Naami B, Al-Hinnawi AR, Visconti P (2024) Automated Lung Cancer Diagnosis Applying Butterworth Filtering, Bi-Level Feature Extraction, and Sparce Convolutional Neural Network to Luna 16 CT Images. J Imaging 10","DOI":"10.3390\/jimaging10070168"},{"key":"1230_CR138","doi-asserted-by":"publisher","first-page":"106808","DOI":"10.3748\/wjg.v31.i21.106808","volume":"31","author":"AE Morales-Galicia","year":"2025","unstructured":"Morales-Galicia AE, Rinc\u00f3n-S\u00e1nchez MN, Ram\u00edrez-Mej\u00eda MM, M\u00e9ndez-S\u00e1nchez N (2025) Outcome prediction for cholangiocarcinoma prognosis: Embracing the machine learning era. World J Gastroenterol 31:106808","journal-title":"World J Gastroenterol"},{"key":"1230_CR139","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12935-021-01988-8","volume":"21","author":"M Zhang","year":"2021","unstructured":"Zhang M, Gao F, Yu X, Zhang Q, Sun Z, He Y, Guo W (2021) LINC00261: a burgeoning long noncoding RNA related to cancer. Cancer Cell Int 21:274","journal-title":"Cancer Cell Int"},{"key":"1230_CR140","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1049\/syb2.12068","volume":"17","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ge W, Xue S, Cui J, Zhang X, Mao T, Xu H, Li S, Ma J, Yue M et al (2023) Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients. IET Syst Biol 17:174\u2013186","journal-title":"IET Syst Biol"},{"key":"1230_CR141","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12935-020-01588-y","volume":"20","author":"H Zhuang","year":"2020","unstructured":"Zhuang H, Huang S, Zhou Z, Ma Z, Zhang Z, Zhang C, Hou B (2020) A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer. Cancer Cell Int 20:493","journal-title":"Cancer Cell Int"},{"key":"1230_CR142","doi-asserted-by":"crossref","unstructured":"Xu G, Ji Y, Wang L, Xu H, Shen C, Ye H, Yang X (2023) M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma. Vaccines (Basel) 11","DOI":"10.3390\/vaccines11030499"},{"key":"1230_CR143","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/cac2.12215","volume":"41","author":"ZH Chen","year":"2021","unstructured":"Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y (2021) Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (Lond) 41:1100\u20131115","journal-title":"Cancer Commun (Lond)"},{"key":"1230_CR144","doi-asserted-by":"crossref","unstructured":"Karabu\u011fa B, Kara\u00e7in C, B\u00fcy\u00fckk\u00f6r M, Bayram D, Aydemir E, Kaya OB, Y\u0131lmaz ME, \u00c7am\u00f6z ES, Erg\u00fcn Y (2025) The Role of Artificial Intelligence (ChatGPT-4o) in Supporting Tumor Board Decisions. J Clin Med 14","DOI":"10.3390\/jcm14103535"},{"key":"1230_CR145","doi-asserted-by":"crossref","unstructured":"Shams A (2024) Leveraging State-of-the-Art AI Algorithms in Personalized Oncology: From Transcriptomics to Treatment. Diagnostics (Basel) 14","DOI":"10.3390\/diagnostics14192174"},{"key":"1230_CR146","doi-asserted-by":"crossref","unstructured":"Zhang Y, Hong L, Li X, Li Y, Zhang X, Jiang J, Shi F, Diao H (2023) M1 macrophage-derived exosomes promote autoimmune liver injury by transferring long noncoding RNA H19 to hepatocytes. MedComm (2020) 4:e303","DOI":"10.1002\/mco2.303"},{"key":"1230_CR147","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.intimp.2021.107402","volume":"93","author":"X Zhu","year":"2021","unstructured":"Zhu X, Zhu Y, Ding C, Zhang W, Guan H, Li C, Lin X, Zhang Y, Huang C, Zhang L et al (2021) LncRNA H19 regulates macrophage polarization and promotes Freund\u2019s complete adjuvant-induced arthritis by upregulating KDM6A. Int Immunopharmacol 93:107402","journal-title":"Int Immunopharmacol"},{"key":"1230_CR148","doi-asserted-by":"publisher","first-page":"115810","DOI":"10.1016\/j.envpol.2020.115810","volume":"268","author":"T Xiao","year":"2021","unstructured":"Xiao T, Zou Z, Xue J, Syed BM, Sun J, Dai X, Shi M, Li J, Wei S, Tang H et al (2021) LncRNA H19-mediated M2 polarization of macrophages promotes myofibroblast differentiation in pulmonary fibrosis induced by arsenic exposure. Environ Pollut 268:115810","journal-title":"Environ Pollut"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01230-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:05:43Z","timestamp":1789034743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01230-x","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"92"}}